Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals Inc is a specialty pharmaceutical company engaged in development and commercialization of therapeutic products for markets using patented or proprietary formulations and modified drug delivery technology.
IPO Date: June 9, 2017
Sector: Healthcare
Industry: Biotech
Market Cap: $14.84M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.07 | 4.20%
Avg Daily Range (30 D): $0.06 | 6.66%
Avg Daily Range (90 D): $0.07 | 5.29%
Institutional Daily Volume
Avg Daily Volume: 1.62M
Avg Daily Volume (30 D): 2.93M
Avg Daily Volume (90 D): 1.17M
Trade Size
Avg Trade Size (Sh.): 422
Avg Trade Size (Sh.) (30 D): 378
Avg Trade Size (Sh.) (90 D): 346
Institutional Trades
Total Inst.Trades: 45
Avg Inst. Trade: $2.78M
Avg Inst. Trade (30 D): $6.8M
Avg Inst. Trade (90 D): $6.8M
Avg Inst. Trade Volume: .06M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $6.35M
Avg Closing Trade (30 D): $6.8M
Avg Closing Trade (90 D): $6.8M
Avg Closing Volume: 149.91K
   
News
Jun 12, 2025 @ 12:35 PM
Citius Pharmaceuticals Announces Closing of Regist...
Source: Prnewswire
Jan 7, 2025 @ 1:08 PM
Citius Pharmaceuticals and Citius Oncology Highlig...
Source: Prnewswire
Jul 31, 2023 @ 7:30 PM
Why Apellis Pharmaceuticals Shares Are Trading Lo...
Source: Lisa Levin
Jul 31, 2023 @ 12:31 PM
Why China Natural Resources Shares Are Trading Hig...
Source: Lisa Levin
Jul 31, 2023 @ 11:13 AM
CSX, Citius Pharmaceuticals And Other Big Stocks M...
Source: Lisa Levin
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-1.27 $-1.31
Diluted EPS $-1.27 $-1.31
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -11.51M $ -10.28M $ -11.08M
Operating Income / Loss $ -11.26M $ -10.04M $ -11.05M
Cost of Revenue $ $ $
Net Cash Flow $ $ $ -23.23M
PE Ratio    
Splits
Nov 26, 2024:   1:25
Jun 09, 2017:   1:15
Sep 12, 2014:   5:8